Bridging Biology, Chemistry And Computation To Design The Best Medicines [Forbes]
Arcelor Mittal NY Registry Shares NEW (MT)
Last arcelor mittal ny registry shares new earnings: 2/6 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
corporate.arcelormittal.com/investors
Company Research
Source: Forbes
Bridging Biology, Chemistry And Computation To Design The Best Medicines Getty Drug discovery has traditionally been a linear, empirical process. The process begins with identifying and validating a target, followed by generating a lead molecule, optimizing its properties and assessing its effectiveness through clinical trials. Through this method, a deep understanding of many disciplines is required. Two of the most pertinent disciplines include biology, the study of living organisms, and chemistry, the study of matter. Biology is used to facilitate the identification and validation of a target, providing insights into the biological underpinnings of disease. Chemistry, on the other hand, is used to ascertain small molecules, including the optimization of lead compounds. The growing connectedness of disciplines has led to promising advancements in drug discovery. Chemical biology Researchers have highlighted the value of chemistry in generating biological therapeutics, like antibodie
Show less
Read more
Impact Snapshot
Event Time:
MT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MT alerts
High impacting Arcelor Mittal NY Registry Shares NEW news events
Weekly update
A roundup of the hottest topics
MT
News
- ArcelorMittal S.A. (NYSE: MT) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $32.90 price target on the stock, up previously from $30.00.MarketBeat
- Stainless Steel Welded Pipe Market to Reach USD 8.9 Billion by 2033, Driven by Strong Demand in Construction and Automotive Sectors | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- ArcelorMittal SA (MT) Q3 2024 Earnings Call Highlights: Resilient Performance Amid Market Challenges [Yahoo! Finance]Yahoo! Finance
- ArcelorMittal S.A.: ArcelorMittal reports third quarter 2024 resultsGlobeNewswire
- ArcelorMittal announces the publication of its third quarter 2024 sell-side analyst consensus figuresGlobeNewswire
MT
Earnings
- 11/7/24 - Beat
MT
Sec Filings
- 11/7/24 - Form 6-K
- 10/28/24 - Form 6-K
- 10/11/24 - Form 6-K
- MT's page on the SEC website